This section provides various financial ratios derived from the company's financial statements to help assess its performance and financial health. Below are Net Profit Margin, Cash Ratio, Current Ratio for QLGN as of 2025-09-30.
| Financial Ratios | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Current Ratio | 882.914 | 70.538 | 101.106 | - |
| Cash Ratio | 787.628 | 5.906 | 1.073 | - |
| Net Profit Margin | -132.646 | -89.731 | -91.981 | -91.934 |
Qualigen Therapeutics, Inc. (QLGN)
Qualigen Therapeutics, Inc. (QLGN)